d -Dimer Testing to Determine the Duration of Anticoagulation Therapy
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 24 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation. METHODS: We performed D-dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years. RESULTS: The D-dimer assay was abnormal in 223 of 608 patients (36.7%). A total of 18 events occurred among the 120 patients who stopped anticoagulation (15.0%), as compared with 3 events among the 103 patients who resumed anticoagulation (2.9%), for an adjusted hazard ratio of 4.26 (95% confidence interval [CI], 1.23 to 14.6; P=0.02). Thromboembolism recurred in 24 of 385 patients with a normal D-dimer level (6.2%). Among patients who stopped anticoagulation, the adjusted hazard ratio for recurrent thromboembolism among those with an abnormal D-dimer level, as compared with those with a normal D-dimer level, was 2.27 (95% CI, 1.15 to 4.46; P=0.02). CONCLUSIONS: Patients with an abnormal D-dimer level 1 month after the discontinuation of anticoagulation have a significant incidence of recurrent venous thromboembolism, which is reduced by the resumption of anticoagulation. The optimal course of anticoagulation in patients with a normal D-dimer level has not been clearly established. (ClinicalTrials.gov number, NCT00264277 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Self-citationKearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Self-citationO'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Research works printed but not linked: 1
- Kearon C, 2003, CMAJ, 168, 183
Cited by
Items 501–600 of 619
d -Dimer and Duration of Anticoagulation
Pernod, G., Sevestre, M., & Labarère, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmc063267 · Cited by 1
Vandy, F. C., & Wakefield, T. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00048-2 · Cited by 1
Duration of anticoagulant therapy after pulmonary embolism can be a tough decision
Quezada, A., & Jiménez, D. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.11.018 · Cited by 1
Madlener, K., & Pötzsch, B. (2010) · Springer eBooks · doi:10.1007/978-3-642-01544-1_68
Luizy, F. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-71346-0.50001-x · Cited by 1
Stellenwert von Globaltests der Gerinnung zur Erfassung des Rezidivrisikos venöser Thromboembolien
Eichinger, S., & Kyrle, P. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Antikoagulation nach Venenthrombosen und Pulmonalembolien
Eichinger, S. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Chávez-Torres, R., Elizalde-Barrera, C. I., Barragán-Jiménez, Z., & Huerta-Ramírez, S. (2013) · Medicina Interna de México
Treatment of Acute Venous Thromboembolism in Hospitalized Patients
Minichiello, T., Doctoroff, L., & Farrell, E. A. (2011) · Wiley eBooks · doi:10.1002/9781118067178.ch7
Clinical and biochemical risk factors for first and recurrent episodes of venous thrombosis
Christiansen, S. C. (2010) · Leiden Repository (Leiden University)
Venous Duplex Ultrasound of the Lower Extremity in the Diagnosis of Deep Venous Thrombosis
Mansour, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4005-4_38
Leung, A. A. C., & Ghali, W. A. (2010) · PubMed Central
Hashemian, S. M. R., & Amir, S. (2012) · InTech eBooks · doi:10.5772/26549
Dargaud, Y. G. (2007) · Hématologie
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence
Piazza, G., Hohlfelder, B., & Goldhaber, S. Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-20843-5_10
Náñez-Terreros, H. (2014) · REMERI - Red Mexicana de Repositorios Institucionales
D-dimer in Diagnosis and Treatment of Pulmonary Embolism
Fijałkowska, A. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27808
“Warto również zauważyć, że kontynuacja leczenia przeciwzakrzepowego u pacjentów z nieprawidłowymi D-dimerami skutkuje istotnym obniżeniem częstości nawrotów, wręcz niższym niż przy prawidłowych D-dimerach [34].”
Zasady leczenia wstępnego i wtórnej profilaktyki przeciwzakrzepowej w zatorze tętnicy płucnej
Kostrubiec, M., & Pruszczyk, P. (2010) · Via Medica Journals
Quel suivi proposer après la première embolie pulmonaire ?
Leroyer, C., Pigearias, B., & Sanchez, O. (2009) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(09)72485-1
A Philosophical Approach to Diagnostic Test Evaluation
Lord, S. J., Irwig, L., & Simes, R. J. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-10-200705150-00016
Conducta diagnóstica y terapéutica ante una sospecha de embolia pulmonar
Parent, F. (2008) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(08)70615-9
Eichinger, S. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.035et
Embolie pulmonaire aiguë : prise en charge actuelle et perspectives
Planquette, B., & Meyer, G. (2011) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(11)70034-9
Le traitement anticoagulant de l’embolie pulmonaire. Quelle durée ?
Tromeur, C., Leroyer, C., & Couturaud, F. (2012) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(12)70314-0
Recurrence after unprovoked venous thromboembolism
Spencer, F. A., & Ginberg, J. S. (2011) · BMJ · doi:10.1136/bmj.d611 · Cited by 1
Guanella, R., & Righini, M. (2010) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2010.02.002
Update in General Internal Medicine
Uchida, T. L., Persell, S. D., & Baker, D. W. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1145-z
Place du dosage plasmatique des D-dimères dans la maladie veineuse thromboembolique
Meyer, G. (2012) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(12)71323-0
Lindhoff‐Last, E. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.036et
Venous thrombosis and thromboembolism
Fitzmaurice, D. A. (2009) · Primary Care Cardiovascular Journal (PCCJ) · doi:10.3132/pccj.2009.023
Heightman, M., & Bellingan, G. J. (2007) · Clinical Medicine · doi:10.7861/clinmedicine.7-3-267
Durée optimale du traitement anticoagulant
Émile, C. (2010) · Option/Bio · doi:10.1016/s0992-5945(10)70351-2
Masotti, L., Antonelli, F., Venturini, E., & Landini, G. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2008.3.23
Eichinger, S. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.035
Practice corner: Chair's rounds
Schmitt, B., Baugh, M. J., & Scaglione, S. (2007) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.12.5.133
Tiefe Venenthrombose – TVT. Diagnose und Therapie
Sturm, W. (2009) · focus neurogeriatrie · doi:10.1007/s12151-009-0182-6
Seinost, G. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Determinants of adverse events during oral anticoagulant treatment
Lind, M. M. (2012) · DiVA at Umeå University (Umeå University)
Doc, is my pulmonary embolism gone?
Goldhaber, S. Z. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.09.009
The Efficiency of Hamilton Pretest Probability Value in Diagnosing Deep Vein Thrombosis
Rampengan, S. H. (2015) · Clinical Medicine Research · doi:10.11648/j.cmr.20150402.14
Tratamiento y prevención secundaria del tromboembolismo
Buitrago, F., Gabardino, J. A. M., & Carmona, J. A. (2011) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(11)70143-8
fEATuRES 98 use of the Passive v oice in Medical Journal Articles
Amdur, R. J., Kirwan, J. M., Morris, C. G., & Wentz, P. (2010)
Asociación de la elevación de la proteína C reactiva con la escala de Villalta
Gutiérrez-Díaz, C. A., Alba, D. A. D., Torres-Martínez, J. A., & Serrano-Lozano, J. A. (2015) · Revista Mexicana de Angiolog�a
Should d-Dimer Testing Guide the Duration of Anticoagulation After Unprovoked VTE?
Krumholz, H. M., & Sm (2006) · Journal watch · doi:10.1056/jc200610250000004
Dimer to Determine Duration of Anticoagulation After Venous Thromboembolism
Brett, A. S. (2006) · Journal watch · doi:10.1056/jw200610310000001
Du bon usage des D-dimères au cours de la maladie thromboembolique veineuse
Levesque, H., & Benhamou, Y. (2015) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2015.06.009
Antikoagulation nach tiefer Venenthrombose
Geier, B., Böhner, H., Balzer, K., Aleksic, M., Nowak, T., Klemp, U., Pillny, M., Kröger, K., & Pourhassan, S. (2013) · Gefässchirurgie · doi:10.1007/s00772-013-1129-5
October 2014 pulmonary case of the month: a big clot
UCSF Fresno, F., Reagle, G. Z., Almasri, E., & Maxwell, S. (2014) · Southwest Journal of Pulmonary and Critical Care · doi:10.13175/swjpcc118-14
Sturm, W. (2009) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-009-0053-9
Démarches diagnostique et thérapeutique devant une suspicion d'embolie pulmonaire
Parent, F. (2007) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(07)34160-4
Three cases of pulmonary embolism after surgery for lung cancer
Kobayashi, Y., Fukui, T., Ito, S., Hatooka, S., & Mitsudomi, T. (2011) · The Journal of the Japanese Association for Chest Surgery · doi:10.2995/jacsurg.25.373
d-Dimer Testing to Determine the Duration of Anticoagulation Therapy
Bissell, M. G. (2008) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)70768-0
Delluc, A., Lacut, K., & Mottier, D. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.10.363
Knabe, P., Yeats, M., Schaftel, J. Z., Lambright, K., Scheve, M., Glendinning, C., & Schwindt, K. (2015) · Kansas Journal of Medicine · doi:10.17161/kjm.v8i1.11518
D-Dimere, das A und O der Thrombose-Diagnostik?
Hoppe, B., & Laboratoriumsmedizin, F. (2013)
2. Measuring hypercoagulability as a risk factor for cardiovascular diseases
Mijovski, M. B. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-822-3_2
Gal, G. L. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.08.028
Anticoagulation Drugs: Indications, Therapeutic Monitoring, and Antidotes
Sharda, A. V., & Zwicker, J. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_44
Duration of Oral Anticoagulation for Venous Thromboembolism
Green, D. (2006) · Journal watch · doi:10.1056/oh200610300000001
Lungenembolie: Interaktive Fälle zur Leitlinie
Drömann, D. (2016) · e Curriculum Innere Medizin · doi:10.1007/s40531-016-0006-7
Pulmoner Embolinin Güncel Tedavisi
Tekin, A. (2016) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.248425
Fink, J. A. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb03324.x
An Analysis of Anticoagulation Treatment for Cancer Patients with Newly Diagnosed VTE
Ikezawa, Y., Sakakibara, J., Shoji, T., Takashima, Y., Morimoto, M., Kikuchi, H., Takashina, T., Oizumi, S., Tsujino, I., & Nishimura, M. (2015) · Haigan · doi:10.2482/haigan.55.1001
Palareti, G. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1366851
“[31], whereas the risk in patients with positive D-dimer is about double those with negative D-dimer [55,71,72].”
BackgroundSelf-citationMój pacjent leczony sulodeksydem — kiedy i dlaczego stosuję?
Gorczyca−Michta, I., & Wożakowska−Kapłon, B. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0109 · Cited by 1
Diagnosis of recurrent deep vein thrombosis
Gal, G. L. (2014) · doi:10.2217/fmeb2013.13.36
Thromboembolic Disease in Cancer
Kazemi, G., Levine, O. H., & Levine, M. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-44227-5.00011-9
Émile, C. (2018) · Option/Bio · doi:10.1016/s0992-5945(18)30346-5
Biomarkers in the Management of Venous Thromboembolism
Carman, T. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54835-9.00014-4
The SURVET study: a new insight into prevention of recurrent venous thromboembolism
Matuška, J. (2017) · Interní medicína pro praxi · doi:10.36290/int.2017.042
Prognostic models for pulmonary embolism
Stein, P. D. (2016) · Wiley eBooks · doi:10.1002/9781119039112.ch66
Method of Preventive Ultrasound Diagnosis of Venous Thrombosis
Ignatyev, I. M. (2019) · Journal for Vascular Ultrasound · doi:10.1177/1544316719839536
“One of the main disadvantage of the method is its low specificity from 39% to 64%, that limits its application in the practice as isolated way without instrumental methods of diagnostics [11,12,13].”
BackgroundThrombophilieabklärung im Hinblick auf östrogenhaltige Kontrazeptiva und Hormonersatztherapie
Pollak, M., & Nagler, M. (2019) · Gynäkologische Endokrinologie · doi:10.1007/s10304-019-0262-y · Cited by 1
Abenante, A., Zuretti, F., Dedionigi, C., Tangianu, F., & Dentali, F. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02249-3
Development of Treatment of Cancer-associated Venous Thromboembolism with Direct Oral Anticoagulants
Hasegawa, Y., Setoguchi, T., Hosono, J., Sakaida, T., & Iuchi, T. (2020) · The Japanese Journal of Phlebology · doi:10.7134/phlebol.19-28
Índices de riesgo de recurrencia en la enfermedad tromboembólica venosa no provocada
López-Núñez, J. J., & Sigüenza, P. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.05.008
Duración de la anticoagulación tras una tromboembolia de pulmón: una decisión no siempre sencilla
Quezada, A., & Jiménez, D. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.11.007
Medvedeva, E. A., Gelis, L., Shumavets, V., & Ивановна, Р. И. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-1-78-86
Linkins, L., & Kearon, C. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch64
Currier, P. F., & Hales, C. A. (2010) · Springer eBooks · doi:10.1007/978-0-387-87429-6_110
Pulmonary Embolism and Deep Vein Thrombosis
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch21
Weg, J. G., Rubenfire, M., & Sofowora, G. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_29
Comerota, A. J., & Barayan, H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1326-8_9
Palareti, G., Prandoni, P., Legnani, C., Antonucci, E., Zorzi, S., Tosetto, A., Bertù, L., Testa, S., Pengo, V., Ageno, W., et al. (2022) · Bleeding Thrombosis and Vascular Biology · doi:10.4081/btvb.2022.10
Self-citationTratamento anticoagulante de longa duração
(2010) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132010001300011
Disorders of pulmonary circulation
Pineo, G. F., & Hull, R. D. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32827ab6a7
Color Venous Duplex Ultrasound of the Lower Extremity in the Diagnosis of Deep Venous Thrombosis
Mansour, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-54760-2_40
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00013-3
Hull, R. D., & Pineo, G. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00062-8
Phelan, H. A. (2018) · Wiley eBooks · doi:10.1002/9781119317913.ch21
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/13780_2016_29
Color Venous Duplex Ultrasound of the Lower Extremity in the Diagnosis of Deep Venous Thrombosis
Mansour, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-49616-6_40-1
Awareness on D-dimer assay among dental students
Anjum, S., Ahmed, N., Ganapathy, D. M., Maiti, S., & Pandurangan, K. K. (2022) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_380_22
“It is usually undetected or only noticeable at an extremely low level unless the body is creating and breaking down the clots.[21] D-dimer is a blood test that tests for it.”
BackgroundYavelov, I. S. (2023) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2022-12-2
Anticoagulant therapy today: from DOACS to factor XI inhibitors
Tondi, P., & Pola, R. (2024) · Acta Phlebologica · doi:10.23736/s1593-232x.24.00635-0
The role of D-dimer in hypertrophic cardiomyopathy requiring myectomy
Kim, K., & Furukawa, Y. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132754
Gruel, Y., Morange, P., Alhenc-Gelas, M., Boissier, É., Gouin‐Thibault, I., de Maistre, E., de Raucourt, E., Desconclois, C., Flaujac, C., Hurtaud, M.-F., et al. (2025) · Revue de biologie médicale. · doi:10.3917/rbm.382.0005
Nishikawa, T., Yamashita, Y., Fujita, M., Morimoto, T., Muraoka, N., Umetsu, M., Nishimoto, Y., Takada, T., Ogihara, Y., Ikeda, N., et al. (2025) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2025.100063
“6 Other studies also reported that abnormal D-dimer levels during the course of anti-coagulation treatment for VTE were associated with a higher thrombotic risk than normal D-dimer levels, suggesting the utility of D-dimer levels after anticoagulation therapy for decision-making regarding…”
Lefebvre, M., Cachanado, M., Châtellier, G., & Emmerich, J. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102928
Metadata
- Authors
- Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., Lensing, A. W. A., & Tripodi, A.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Ospedale San Bortolo (IT)
- University of Perugia (IT)
- Azienda Ospedale - Università Padova (IT)
- Santa Maria Nuova Hospital (IT)
- Istituti Ospitalieri di Cremona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-10-26
- Volume
- 355
- Issue
- 17
- Pages
- 1780-1789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2047986798
- Cited by
- 622
- References
- 25
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 16 · 2020: 34 · 2019: 22 · 2018: 20 · 2017: 19 · 2016: 40 · 2015: 41 · 2014: 40 · 2013: 38 · 2012: 53
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Keywords
- D-dimer, anticoagulation duration, venous thromboembolism, deep vein thrombosis, pulmonary embolism, vitamin K antagonists, recurrence, major bleeding, unprovoked thrombosis, anticoagulation resumption
- MeSH terms
- Acenocoumarol, Adult, Aged, Aged, 80 and over, Anticoagulants, Antithrombins, Drug Administration Schedule, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Hemorrhage, Humans, Middle Aged, Prospective Studies, Pulmonary Embolism, Recurrence, Ultrasonography, Vitamin K, Warfarin, Proportional Hazards Models, Survival Analysis, Antiphospholipid Syndrome, Venous Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.